SCHEMBL14224313

SCHEMBL14224313

C=CCOC(=O)CO/N=C1\CN(C(=O)OC(C)(C)C)Nc2ccccc21

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.37
MAPK1 P28482 1/20 0.34
CYP19A1 P11511 1/20 0.32
RHOA P61586 1/20 0.31
MAPK8 P45983 1/20 0.31
MAPK9 P45984 1/20 0.31
MAPK10 P53779 1/20 0.31
HPGD P15428 2/20 0.31
ALDH1A1 P00352 1/20 0.31
CYP3A4 P08684 1/20 0.30
PKM P14618 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
LMNA P02545 1/20 0.30
MAPT P10636 1/20 0.30
HTT P42858 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4865746 1.00 NPSR1 (0.37) NPSR1MAPK1CYP19A1RHOAMAPK8
SCHEMBL14196720 0.90 MAPK1 (0.38) NPSR1MAPK1CYP19A1RHOAHPGD
SCHEMBL4860414 0.90 MAPK1 (0.38) NPSR1MAPK1CYP19A1RHOAHPGD
SCHEMBL5320440 0.87 NPSR1 (0.40) NPSR1CYP19A1RHOAMAPK8MAPK9
SCHEMBL14196724 0.84 NPSR1 (0.41) NPSR1CYP19A1RHOAMAPK8MAPK9
SCHEMBL4863074 0.84 MAPK1 (0.39) MAPK1MAPK8MAPK9MAPK10HPGD
SCHEMBL14196714 0.84 MAPK1 (0.39) MAPK1MAPK8MAPK9MAPK10HPGD
SCHEMBL14425277 0.84 MAPK1 (0.40) MAPK1ALDH1A1PKM
SCHEMBL4856100 0.79 MAPK1 (0.38) MAPK1SMN1; SMN2
SCHEMBL5321196 0.76 CYP3A4 (0.35) NPSR1RHOAALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7365071-B2 Heterocyclic compounds, preparation process and intermediates, and use as medicaments, in particular as β-lactamase inhibitors and antibacterials AVENTIS PHARMA S.A. (FR) 2008-04-29 US disclosed